Aranca's research experience in the pharmaceutical sector spans several segments like pharmacology, pharamaceutics, medicinal chemistry, pharmacognosy (herbal drugs), biochemistry, bio-pharamaceutics and veterinary medicines.

We support several global pharma companies, law firms, universities and technology transfer firms with novelty, freedom-to-operate, invalidation and landscape studies for new chemical entities, drug molecules, formulations or compositions and other niche areas such as chemical structure, traditional knowledge search and drug report preparation i.e. orange book analysis, clinical trial information and analysis of FDA data.

Track Record



Projects conducted.



Pharmaceutical technologies covered by our consultants.



Clients including Pharma and Biotech companies.



Man hours of research experience.

Examples of Our Work in the Pharmaceutical Sector

Technology Intelligence

R&D Strategy Roadmaps

  • Future applications of nanotechnology in cancer diagnostic
  • Technology roadmap for use of PEGylated pharmaceutical in drug delivery
  • Identification of new salt forms of statin-based HMG-CoA reductase inhibitors of cholesterol lowering drugs

White Space Analysis

  • Identification of unmet needs pertaining to implantable hormonal contraceptives
  • White space analysis related to pharmacokinetic property of antifungal drugs from azole category
  • Problem-solution matrix for technologies pertaining to delivery of proteins via oral route

Technology Landscape | Innovation Focus

  • Research trend analysis related to use of solubility enhancement methods for oral solid dosage forms
  • Identification of technologies pertaining to drug screening
  • Technology landscape study on manufacturing and application of stem cells in pharmaceutical and dermo-cosmetics

Monetizing Existing Technical Know-how

  • Valuation of a patent related to solubility enhancement technique
  • Royalty rate estimation for in-licensing a patent related to synthesis method for imidazole class of compounds
  • Potential partner identification for technology pertaining to a molecular imprinted polymers for drug delivery

Technology Scouting and Acquisition

  • Scouting for technologies on super-disintegrant used in oro-dispersible table
  • Solution identification for problems related use of silicon particles in drug delivery
  • Feasibility analysis of using indigenous polysaccharide for wound-care preparation

Product Design for Emerging Technologies/ Markets

  • Use of antioxidant in parenteral solution preparation
  • Scouting for various drug delivery system that can be used for delivering nitro-glycerine based drug for treating myocardial infraction
  • Technology assessment pertaining to use of high pressure homogeniser for nano drug development

IP Strategy

Prosecution Support

  • Novelty search related to use of xyloglucan based polymer in sublingual tablet formulation
  • Patentability study for a combination of antihypertensive and antilipidemic drug combination
  • Patent drafting for technology pertaining to use of dosage regime for long term hormonal contraceptive therapy

Prior Art Searches

  • Prior art search related to delayed release composition containing testosterone derivatives
  • State of art search modified mannitol as a binder in oral pharmaceutical composition
  • Invalidity search related to use of colloidal-silica with improved bulk density and improved flow characteristic

Portfolio Analysis

  • Patent quality assessment for a patent portfolio related to nicotine replacement products
  • Identification of key patents for licensing purpose from portfolio related to auto-injector drug delivery systems
  • Patent portfolio analysis of companies dealing in technologies pertaining to treatment of bacterial infections in ruminant animals

Technology/ Patent Landscape

  • Technology landscape study related to spectrometric method for protein formulation analysis
  • Competitive landscape for new antibacterial chemical entities for infectious diseases
  • Benchmarking of patent portfolio related to solid lipid nanoparticles for topical drug delivery

Clinical Trial Study Support

  • Identification of new chemical entity for treatment of HIV disease that are in the research pipeline of the pharmaceutical company
  • Identification of the new drug combination that are under research for the treatment of excessive hypertension conditions
  • Identification of the key players that are conducting clinical trials for edible vaccines

Drug Approval and Patent Expiry Study Support

  • Identification of the patented anticancer drug combination that are going off-patent in the United States and Europe
  • Identification of the patented derivatives of the tyrosine-kinase inhibitor based anticancer drugs and their respective expiry date in various geography
  • Identification of the antihistaminic drugs that are OTC approved

Looking for help with Technology Intelligence, IP Strategy, or Litigation support?

Knowledge Library

  1. 1
  2. 2
  3. 3
    Biopharma: Roadmap to Success

    Ranked among the 12 major biotech destinations across APAC region, Indian biotechnology market largely banks on biopharmaceuticals, which account for a major share of this growing

  1. 1
  2. 2
  3. 3
  1. 2
  2. 3
  1. Evolution of Powered Exoskeletons

    Envisaged over a hundred years ago as a steam-powered set of locomotive legs, we’ve come a long way in our quest to seriously suit-up.

  2. 2
  3. CRISPR/Cas9 – Market Players Snapshot

    We're entering a new era in molecular biology. A new tool based on a bacterial CRISPR-associated protein-9 nuclease (Cas9) from Streptococcus pyogenes will enable the

  4. 3
  1. How to Get the Most Out of IP Financing

    The use of intellectual property as collateral to obtain finance is an increasingly common phenomenon. Over the past three decades, the proportion of tangible assets

  2. 2
  3. The Internet of Medical Things (IoMT)

    A healthcare application of IoT technologies, the concept of Internet of Medical Things (IoMT) envisions a network of connected devices that sense vital data in

  4. 3
  5. Cardiac Nuclear Imaging and Radiotracers

    Recent novel radiopharmaceuticals agents developed to target specific subcellular process are capable of significantly improving diagnostic accuracy and prognostic evaluation. The global nuclear medicine diagnostic